EUVIMEDEUVIMED entdecken
Open Access

Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application

Ryan G Rilinger iD, Andrew Dhawan iD

Neuro-Oncology · 01.06.2026 · 28 (6) · 1588-1589

DOI: 10.1093/neuonc/noag048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 07.03.2026. Verfasst von Ryan G Rilinger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine, Case Western Reserve University (R.G.R., A.D.). Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University (R.G.R., A.D.).
  • Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic (R.G.R., A.D.).
  • Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic (R.G.R., A.D.).

ORCID-Profile: Ryan G Rilinger, Andrew Dhawan

Zitieren

APA

Rilinger, R. G., & Dhawan, A. (2026). Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application. Neuro-Oncology, 28(6), 1588-1589. https://doi.org/10.1093/neuonc/noag048

Vancouver

Rilinger RG, Dhawan A. Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application. Neuro-Oncology. 2026;28(6):1588-1589. doi:10.1093/neuonc/noag048

BibTeX
@article{Rilinger2026,
  author = {Rilinger, Ryan G and Dhawan, Andrew},
  title = {Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application},
  journal = {Neuro-Oncology},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {1588--1589},
  doi = {10.1093/neuonc/noag048}
}
Kostenlos starten →